Teleflex Incorporated (TFX)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE
Market Cap: $6.15B
Last updated: Nov 17, 2026 at 4:25 PM ET
Teleflex Incorporated (TFX) Statistics
Teleflex (TFX) has a market cap of $6.15B and an enterprise value of $7.50B. Revenue grew 47.41% over the last 12 months from the 12 months before. Its share count is down 6.22% from a year earlier.
Total Valuation
Enterprise value is 21.94% above the market cap, as debt exceeds cash.
| Market Cap | $6.15B |
|---|---|
| Enterprise Value | $7.50B |
| Latest price (Nov 17, 2026) | $159.57 |
Key Dates
The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 16, 2026.
| Next Earnings Date | Feb 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Last Ex-Dividend Date | Nov 16, 2026 |
| Next Payment Date | Dec 31, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 5.2x and 1.9x. Its year-end P/E ranged from 10.0x to 38.6x from 2016 to 2025.
| P/E Ratio | 20.7x |
|---|---|
| Forward P/E | 20.8x |
| P/S Ratio | 5.2x |
| Forward P/S | 2.7x |
| P/B Ratio | 1.9x |
| P/FCF Ratio | 75.7x |
| P/OCF Ratio | 43.2x |
Enterprise Valuation
Counting debt and cash, the company is valued at 13.9x EBITDA and 91.1x free cash flow.
| EV / Earnings | 24.6x |
|---|---|
| EV / Sales | 5.8x |
| EV / EBITDA | 13.9x |
| EV / EBIT | 16.9x |
| EV / FCF | 91.1x |
Price Statistics
The stock is up 49.58% over 52 weeks and trades 18.98% above its 50-day average.
| Beta (1Y) | 0.47 |
|---|---|
| 52-Week Change | +49.58% |
| 1-Month Change | +23.32% |
| 3-Month Change | +17.71% |
| 6-Month Change | +20.82% |
| 5-Year Change | -60.84% |
| 10-Year Change | -2.35% |
| Total Return (1Y) | +50.85% |
| Total Return (3Y CAGR) | -8.71% |
| Total Return (5Y CAGR) | -13.10% |
| Return vs SPY (1Y) | +37.37% |
| Max Drawdown (1Y) | -23.75% |
| Max Drawdown (3Y) | -60.50% |
| Sharpe Ratio (1Y) | 1.07 |
| Correlation with SPY (1Y) | 0.17 |
| 50-Day Average | $134.11 |
| 200-Day Average | $127.60 |
| 52-Week Range | $99.17 to $157.65 |
| RSI (14 Days) | 77.6 |
| Average Volume (20 Days) | 877.70K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.01x current liabilities, and total debt is 0.51x shareholder equity.
| Current Ratio | 2.01x |
|---|---|
| Quick Ratio | 1.59x |
| Debt / Equity | 0.51x |
| Debt / EBITDA | 3.11x |
| Debt / FCF | 20.35x |
| Interest Coverage | 4.14x |
Returns and Efficiency
Return on invested capital is 8.37% over the last 12 months, against a 5-year average of 4.75%.
| Return on Equity (ROE) | 8.72% |
|---|---|
| Return on Assets (ROA) | 4.80% |
| Return on Invested Capital (ROIC) | 8.37% |
| Return on Capital Employed (ROCE) | 8.19% |
| ROE (5Y Average) | 0.53% |
| ROA (5Y Average) | 1.00% |
| ROIC (5Y Average) | 4.75% |
| Asset Turnover | 0.18x |
| Inventory Turnover | 1.16x |
| Receivables Turnover | 3.45x |
| Cash Conversion Cycle | 298 days |
Taxes
Income tax took 0.71% of pretax income over the last 12 months.
| Income Tax (TTM) | $2.44M |
|---|---|
| Effective Tax Rate | 0.71% |
Scores
TFX has an Altman Z-Score of 2.00, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.00 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $1.28B over the last 12 months.
| Revenue | $1.28B |
|---|---|
| Revenue Growth (YoY) | +47.41% |
| Gross Profit | $856.51M |
| Operating Income | $444.82M |
| Pretax Income | $343.37M |
| Net Income | $304.64M |
| EBITDA | $572.46M |
| EBIT | $444.82M |
| Reported EPS (TTM) | $7.71 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 54.96% of the $6.35B in total assets.
| Cash and Equivalents | $430.46M |
|---|---|
| Total Debt | $1.78B |
| Net Debt | $1.35B |
| Net Debt Per Share | $32.53 |
| Working Capital | $927.57M |
| Shareholder Equity | $3.49B |
| Book Value Per Share | $84.22 |
| Tangible Book Value | -$199.35M |
| Total Assets | $6.35B |
| Total Liabilities | $2.85B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $55.09M of capital spending, operating cash flow left $87.46M of free cash flow.
| Operating Cash Flow | $142.54M |
|---|---|
| Capital Expenditures | $55.09M |
| Free Cash Flow | $87.46M |
| FCF Per Share | $2.06 |
| Depreciation and Amortization | $191.10M |
| Dividends Paid | $58.77M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 34.63%, against a 5-year average of 13.48%.
| Gross Margin | 66.68% |
|---|---|
| Operating Margin | 34.63% |
| Pretax Margin | 26.73% |
| Net Margin | 23.72% |
| EBITDA Margin | 44.57% |
| EBIT Margin | 34.63% |
| FCF Margin | 6.81% |
| Gross Margin (5Y Average) | 57.61% |
| Operating Margin (5Y Average) | 13.48% |
| Net Margin (5Y Average) | 1.95% |
Growth
Revenue fell 10.62% a year over 3 years, and EPS 2.14% a year.
| Revenue Growth (3Y CAGR) | -10.62% |
|---|---|
| Revenue Growth (5Y CAGR) | -4.72% |
| EPS Growth (3Y CAGR) | -2.14% |
| EPS Growth (5Y CAGR) | +2.78% |
| FCF Growth (3Y CAGR) | -82.36% |
| FCF Growth (5Y CAGR) | -66.57% |
| Operating Income Growth (3Y CAGR) | -38.13% |
| Book Value Per Share Growth (2Y CAGR) | -13.26% |
Dividends and Yields
TFX pays out 39.58% of earnings as dividends.
| Dividend Per Share (Annual) | $1.36 |
|---|---|
| Dividend Yield | 0.85% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | 0.00% |
| Dividend Growth (5Y CAGR) | 0.00% |
| Payout Ratio | 39.58% |
| FCF Payout Ratio | 67.20% |
| Earnings Yield | 4.83% |
| FCF Yield | 1.32% |
| Buyback Yield | 8.38% |
| Shareholder Yield | 9.27% |
Peer Position
Against 10 similar companies, TFX has the 6th highest P/E and the 4th highest ROIC.
P/E RatioPeer median 20.1x
P/S RatioPeer median 2.8x
ROICPeer median 5.42%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +6.20%
Dividend YieldPeer median 0.00%
| P/E Ratio | 20.7x vs 20.1x median |
|---|---|
| P/S Ratio | 5.2x vs 2.8x median |
| ROIC | 8.37% vs 5.42% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +47.41% vs +6.20% median |
| Dividend Yield | 0.85% vs 0.00% median |
Analyst Forecast
Consensus estimates put revenue growth at 8.59% and EPS growth at -5.44% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +8.59% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | -5.44% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About TFX
What is TFX's market cap?
Teleflex has a market cap of $6.15B. Its enterprise value, which adds debt and subtracts cash, is $7.50B.
What is TFX's P/E ratio?
Teleflex has a trailing P/E ratio of 20.7x and a forward P/E of 20.8x.
How many shares of TFX are outstanding?
Teleflex has 41.48M shares outstanding. The count is down 6.22% from a year earlier.
Does TFX pay a dividend?
Yes. Teleflex pays $1.36 a share a year, a dividend yield of 0.85%.
How much debt does TFX have?
Teleflex has $1.78B of total debt and $430.46M of cash and equivalents, a net debt position of $1.35B.
TFX pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts